CTXR
Citius Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.96M
P/E Ratio
—
EPS
$-2.14
Beta
0.98
52W High
$2.48
52W Low
$0.48
50-Day MA
$0.71
200-Day MA
$0.97
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.32
PEG Ratio
0.00
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Fundamentals
| Revenue (TTM) | $5.61M |
| Gross Profit (TTM) | $4.49M |
| EBITDA | $-53.85M |
| Operating Margin | -1828.00% |
| Return on Equity | -83.60% |
| Return on Assets | -27.60% |
| Revenue/Share (TTM) | $0.31 |
| Book Value | $2.75 |
| Price-to-Book | 0.25 |
| Price-to-Sales (TTM) | 2.85 |
| EV/Revenue | 2.115 |
| EV/EBITDA | -2.74 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $27.45M |
| Float | $26.96M |
| % Insiders | 1.79% |
| % Institutions | 3.63% |
Historical Volatility
HV 10-Day
64.48%
HV 20-Day
130.16%
HV 30-Day
113.55%
HV 60-Day
122.29%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($4.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026